Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation

Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, including asthma, atopic dermatitis, ulcerative colitis and more.

Imbria touts PhII success in hypertrophic cardiomyopathy, adding fuel to overall efficacy profile

Imbria Pharmaceuticals’ partial fatty acid oxidation inhibitor improved outcomes in Phase II non-obstructive hypertrophic cardiomyopathy patients, with the company noting that the asset’s efficacy could

November 8, 2023

Late-night REM sleep loss severely impacts brain connectivity, new study reveals

Research reveals that REM sleep deprivation disrupts brain connectivity, with the thalamus playing a key role in sensory information relay and REM sleep regulation.

July 4, 2024

Weight Management Cuts Cardiovascular Risks in Breast Cancer Survivors

Findings from a retrospective cohort study at the San Antonio Breast Cancer Symposium showed that weight management strategies, such as nutrition counseling and bariatric surgery,

January 4, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.